Ciprofloxacin Kit
NDC Package 62135-392-42

11-digit billing NDC: 62135039242 · Billing unit: ML

Package Information

Ciprofloxacin kits is ciprofloxacin Oral Suspension is supplied in 5% (5 g ciprofloxacin in 100 mL) and 10% (10 g ciprofloxacin in 100 mL) strengths. This formulation utilizes a kit delivery system. Marketed by Chartwell Rx, Llc, this product is identified by NDC 62135-392 and is authorized under FDA application ANDA200563.

Identification & Billing

NDC Package Code
62135-392-42
Package Description
1 KIT in 1 KIT * 100 mL in 1 BOTTLE * 100 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
62135039242
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ciprofloxacin
Non-Proprietary Name
Ciprofloxacin
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Ciprofloxacin Oral Suspension is supplied in 5% (5 g ciprofloxacin in 100 mL) and 10% (10 g ciprofloxacin in 100 mL) strengths. Ciprofloxacin for Oral Suspension is composed of two components (granular blend and diluent) that must be combined prior to dispensing.Table 5: Appropriate Dosing Volumes of the Reconstituted Oral SuspensionsDose5%(250 mg/5 mL)10%(500 mg/5 mL)250 mg5 mL2.5 mL500 mg10 mL5 mL750 mg15 mL7.5 mLPreparation of the suspension:Step 1:The small bottle contains the granular blend and the large bottle contains the diluent. Shake the diluent bottle for about 30 seconds.Step 2:Open the bottles containing granular blend and the diluent. Child-proof cap: Press down according to instructions on the cap while turning to the left. Step 3:Pour the granular blend completely into the larger bottle of diluent. Do not add water to the suspension.Step 4:Remove the top layer of the diluent bottle label (to reveal the Ciprofloxacin for Oral Suspension, USP label). Close the large bottle tightly. Shake vigorously for about 30 seconds to form uniform dispersion. The suspension is ready for use.Step 5:Write the expiration date of the re-constituted oral suspension on the bottle label.Reconstituted product may be stored below 30°C (86°F) for 14 days. Protect from freezing.No additions should be made to the mixed final ciprofloxacin suspension. Ciprofloxacin for Oral Suspension should not be administered through feeding or NG (nasogastric) tubes due to its physical characteristics.

Regulatory & Marketing

Labeler Name
Chartwell Rx, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA200563
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-05-2014
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62135-392-42 identifies a specific commercial package of 1 kit in 1 kit * 100 ml in 1 bottle * 100 ml in 1 bottle of Ciprofloxacin, a human prescription drug labeled by Chartwell Rx, Llc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chartwell Rx, Llc on March 05, 2014. The current certification is valid through December 31, 2027.

How is this Chartwell Rx, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62135039242. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62135-392-42
11-Digit CMS (5-4-2)
62135-0392-42

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.